Is Canopy Growth Stock Going to $0?

Core Viewpoint - Canopy Growth's stock has significantly declined from over $300 to under $2, raising questions about its future viability and potential recovery [1] Financial Performance - Canopy Growth's net revenue for Q3 of fiscal year 2026 was CA$74.5 million ($54.5 million), showing little year-over-year growth [2] - The company reported a net loss per share of CA$0.18 ($0.13), an improvement from the previous year's loss of CA$1.11 ($0.81) per share [2] - The improvement in net loss was primarily due to a reduction in share-based compensation, a non-cash expense, rather than operational improvements [5] - Free cash flow for the period was CA$19 million ($13.9 million), down from CA$28.2 million ($20.6 million) in the prior-year quarter, indicating ongoing financial struggles [5] Regulatory Environment - Canopy Growth has a U.S. subsidiary and is awaiting federal cannabis legalization to enter the U.S. market [6] - An executive order by President Trump reclassifying cannabis to Schedule III could facilitate banking access and business expense deductions for marijuana companies [6][7] - Despite potential regulatory changes, major indexes like Nasdaq may not list companies that violate U.S. federal law, which poses a challenge for Canopy Growth [7] - Cannabis sales remain illegal at the federal level in the U.S., but Canopy Growth operates legally in Canada, allowing its Nasdaq listing [8]